For instance, in the field I work in you have to spend days to months waiting for tumors to grow and then go and treat the animals every day for a couple of weeks with an IV drug (weekends too!). That is a a lot of work and at the end only tells you one piece of information about the drug: does it slow tumor growth in this one experimental model. It may in fact do that -- and you may get a really great p-value if you increase the number of mice -- but you still need to study the drug's pharmacokinetics, tissue distribution, in vivo mechanism of action (assuming you already know the in vitro mechanism of action). These are not just optional experiments that we require today to publish: this kind of work is essential to presenting a story about a new drug. It's not just about what it does, but how it works and universalizable it is.